Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis [Phase 2]
A Phase 2 clinical trial evaluating ZL-1102 for chronic plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries
This clinical trial update notes the completion of a study evaluating ustekinumab for plaque psoriasis in Asia-Pacific countries.
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating safety, tolerability, and pharmacodynamic effects of a new anti-…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients [Phase 4]
Phase 4 study evaluated the efficacy and tolerability of topical skincare products in patients with psoriasis, including plaque psoriasis, a…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity [Phase 3]
Phase 3 trial comparing Hulio (adalimumab biosimilar) to Humira evaluates pharmacokinetics, efficacy, safety and immunogenicity to support i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-10-10FDA Approved: IMULDOSA — Original Application (Accord BioPharma Inc.)
The FDA approves Imuldosa (ustekinumab-srlf) from Accord BioPharma Inc. under an Original Biologics License Application, expanding treatment…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis. [Phase 2]
Phase 2 trial PF-07038124 in patients with Atopic dermatitis and Plaque psoriasis has completed, with results posted on 2024-10-02.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis [Phase 4]
Phase 4 trial comparing early Secukinumab 300 mg subcutaneous injections to narrow-band UVB in new-onset moderate-to-severe plaque psoriasis…
-
FDA approval · 2024-09-27FDA Approved: OTULFI — Original Application (Fresenius Kabi USA, LLC)
FDA approved OTULFI (ustekinumab-aauz) from Fresenius Kabi USA, LLC, as an original application. OTULFI is a monoclonal antibody targeting I…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) [Phase 1]
A Phase 1 clinical trial evaluating certolizumab pegol (Cimzia) in pregnant women with chronic inflammatory diseases has completed and poste…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO) [NA]
This clinical trial update indicates that a study evaluating therapeutic drug monitoring of brodalumab in adults with plaque psoriasis is cu…
-
FDA approval · 2024-09-11FDA Approved: TREMFYA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for TREMFYA (guselkumab) submitted by Janssen Biotech, Inc., affecting the drug's approved labeling …
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Jiuweihuaban Pill for plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity Index
A clinical trial is evaluating a multimodal high-frequency ultrasound-based method to assess psoriasis severity (Plaque psoriasis severity i…
-
FDA approval · 2024-08-26FDA Approved: ADALIMUMAB-RYVK — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for ADALIMUMAB-RYVK, a biosimilar to adalimumab, submitted by Quallent Pharmaceuticals Health LL…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
A Phase 3 trial compared pharmacokinetics, efficacy, and safety of CT-P17 with Humira in adults with moderate to severe chronic plaque psori…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685 [Phase 1]
Phase 1 clinical trial update for ONO-4685 evaluating safety, tolerability, PK/PD, and preliminary efficacy in plaque psoriasis. The study h…
-
FDA approval · 2024-08-12FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for SILIQ (brodalumab) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 bioequivalence study comparing two treatments for plaque psoriasis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region [Phase 4]
Phase 4 trial evaluating the efficacy and safety of VTAMA (tapinarof) 1% cream for plaque psoriasis in the head and neck region has complete…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis [Phase 2]
A Phase 2 clinical trial evaluating ESK-001 for plaque psoriasis has completed, with results posted.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
An ongoing real-world observational study comparing Deucravacitinib versus Apremilast for adults with plaque psoriasis is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults [Phase 3]
Investigator-initiated Phase 3 trial of Duobrii lotion for mild plaque psoriasis in adults has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects [Phase 1]
A Phase 1 study evaluating a single dose of ILV-095 in adults with plaque psoriasis was terminated; results have been posted.
-
FDA label_change · 2024-07-02FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for SILIQ (brodalumab) submitted by Bausch Health US LLC to update the product labeling. The action …